MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

A.I. Advisor
published Earnings

SUPN is expected to report earnings to fall 52.65% to 32 cents per share on March 04

Supernus Pharmaceuticals SUPN Stock Earnings Reports
Q4'24
Est.
$0.33
Q3'24
Beat
by $0.25
Q2'24
Beat
by $0.37
Q1'24
Missed
by $0.38
Q4'23
Missed
by $0.54
The last earnings report on November 04 showed earnings per share of 68 cents, beating the estimate of 43 cents. With 55.23K shares outstanding, the current market capitalization sits at 1.84B.
View a ticker or compare two or three
SUPN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com